Trips Agreement Notes In Hindi
A 2003 agreement eased the requirements of the domestic market and allows developing countries to export to other countries where there is a national health problem as long as the exported medicines are not part of a trade or industrial policy.  Drugs exported under such a regime may be packaged or coloured differently to prevent them from harming the markets of industrialized countries. The TRIPS Agreement is the only international agreement detailing the enforcement of intellectual property rights, including rules on evidence, interim measures, injunctions, damages and other sanctions. It stipulates that, under certain conditions, courts must have the right to order the order or destruction of property that infringes intellectual property rights. Intentional trademark infringement or commercial piracy must be punishable. Governments must also ensure that holders of intellectual property rights can benefit from the assistance of customs authorities to prevent the importation of counterfeit and illegally manufactured goods. Like the General Agreement on Tariffs and Trade (GATT) and the General Agreement on Trade in Services (GATS), the TRIPS Agreement was based on fundamental principles. And, as in the other two agreements, non-discrimination is at the forefront: national treatment (treatment of foreigners no less favourable than its own nationals) and most-favoured-nation treatment (no discrimination against nationals of trading partners). Infätisation is also a key principle in other intellectual property agreements outside the WTO. While the WTO agreements of the 1st the TRIPS Agreement granted certain transitional periods to WTO members before being required to apply all of its provisions. Members of industrialized countries have been given one year to ensure that their laws and practices are in line with the TRIPS Agreement. Developing countries and countries with economies in transition (under certain conditions) were granted a period of five years, until the year 2000.
The least developed countries were initially 11 years old, until 2006, and generally until 1 July 2021. TRIPS conditions that impose more standards beyond TRIPS were also discussed.  These free trade agreements contain conditions that limit the ability of governments to introduce competition from generic drug manufacturers. . . .